• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测局限性前列腺癌男性治疗选择及对治疗决策满意度的因素。

Factors that predict treatment choice and satisfaction with the decision in men with localized prostate cancer.

作者信息

Berry Donna L, Ellis William J, Russell Kenneth J, Blasko John C, Bush Nigel, Blumenstein Brent, Lange Paul H

机构信息

University of Washington, Seattle, WA 98195-7266, USA.

出版信息

Clin Genitourin Cancer. 2006 Dec;5(3):219-26. doi: 10.3816/CGC.2006.n.040.

DOI:10.3816/CGC.2006.n.040
PMID:17239276
Abstract

PURPOSE

Men diagnosed with localized prostate cancer (LPC) often have the opportunity to participate in the treatment choice. The purpose of this study was to evaluate relationships between influential factors on treatment choice and the decision-related outcomes of decisional conflict and satisfaction.

PATIENTS AND METHODS

This report presents data from 260 men diagnosed with LPC who were identified by their clinicians as having a choice of treatments. Men completed questionnaires at home within 2 weeks of the informational clinic visit with the clinician, but before treatment. The respondent sample had a mean age of 63.2 years (standard deviation, 8.1 years); the majority were married/partnered (82.7%), working (51.5%), white (93.8%), and educated at the collegiate level (83.8%). Personal factors (information, influential people, and outcomes), treatment choice, and decisional conflict and satisfaction with the decision (SWD) were queried. Relationships between all variables and the outcomes, SWD, and treatment choice were explored using exhaustive chi(2) automatic interaction detector.

RESULTS

The strongest predictor partition variable for SWD was the subscale "factors contributing to uncertainty" (adjusted P < 0.0001) followed by the Trait Anxiety score (adjusted P = 0.0388). The strongest predictive partition for the actual treatment choice was age group (adjusted P < 0.0001), followed by interacting marital status (adjusted P = 0.0003), influence of the urologist (adjusted P = 0.0008), and use of the Internet (adjusted P = 0.0479). Men with LPC were more satisfied with their treatment choice when they reported fewer uncertainty factors; these are factors mainly relevant to information needed to understand the pros and cons and to make a decision. Consistent with this finding for treatment choice is the use of the Internet, though this factor interacted with age, the influence of their surgeon, and marital status.

CONCLUSION

This study suggests that personally meaningful information communicated between patients and clinicians is paramount.

摘要

目的

被诊断为局限性前列腺癌(LPC)的男性通常有机会参与治疗选择。本研究的目的是评估影响治疗选择的因素与决策冲突和满意度等决策相关结果之间的关系。

患者与方法

本报告呈现了260名被诊断为LPC的男性的数据,这些男性被其临床医生认定有多种治疗选择。男性在与临床医生进行信息门诊就诊后的2周内、治疗前在家中完成问卷。应答者样本的平均年龄为63.2岁(标准差8.1岁);大多数人已婚/有伴侣(82.7%)、有工作(51.5%)、为白人(93.8%)且受过大学教育(83.8%)。询问了个人因素(信息、有影响力的人及结果)、治疗选择以及决策冲突和对决策的满意度(SWD)。使用穷举卡方自动交互检测器探索所有变量与结果、SWD和治疗选择之间的关系。

结果

SWD的最强预测划分变量是子量表“导致不确定性的因素”(校正P<0.0001),其次是特质焦虑得分(校正P = 0.0388)。实际治疗选择的最强预测划分是年龄组(校正P<0.0001),其次是交互婚姻状况(校正P = 0.0003)、泌尿科医生的影响(校正P = 0.0008)和互联网的使用(校正P = 0.0479)。当报告的不确定性因素较少时,LPC男性对其治疗选择更满意;这些因素主要与理解利弊和做出决策所需的信息相关。与治疗选择的这一发现一致的是互联网的使用,尽管该因素与年龄、外科医生的影响和婚姻状况存在交互作用。

结论

本研究表明患者与临床医生之间传达的个人有意义信息至关重要。

相似文献

1
Factors that predict treatment choice and satisfaction with the decision in men with localized prostate cancer.预测局限性前列腺癌男性治疗选择及对治疗决策满意度的因素。
Clin Genitourin Cancer. 2006 Dec;5(3):219-26. doi: 10.3816/CGC.2006.n.040.
2
Prospective study of men's psychological and decision-related adjustment after treatment for localized prostate cancer.局限性前列腺癌治疗后男性心理及决策相关调适的前瞻性研究。
Urology. 2004 Apr;63(4):751-6. doi: 10.1016/j.urology.2003.11.017.
3
Comparing a generic and individualized information decision support intervention for men newly diagnosed with localized prostate cancer.比较针对新诊断为局限性前列腺癌的男性的通用信息决策支持干预和个性化信息决策支持干预。
Cancer Nurs. 2007 Sep-Oct;30(5):E7-15. doi: 10.1097/01.NCC.0000290819.22195.d6.
4
Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer.患者对主动监测作为低危前列腺癌治疗选择的接受度。
BJU Int. 2011 Dec;108(11):1787-93. doi: 10.1111/j.1464-410X.2011.10200.x. Epub 2011 Apr 20.
5
Information and decision-making preferences of men with prostate cancer.前列腺癌男性的信息及决策偏好
Oncol Nurs Forum. 1995 Oct;22(9):1401-8.
6
Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the Prostate Cancer Outcomes Study.临床局限性前列腺癌患者对治疗决策的满意度。前列腺癌结局研究结果。
Cancer. 2003 Apr 1;97(7):1653-62. doi: 10.1002/cncr.11233.
7
Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance.影响主动监测前列腺癌患者治疗决策和信息偏好的因素。
Patient Educ Couns. 2012 Jun;87(3):369-74. doi: 10.1016/j.pec.2011.11.009. Epub 2011 Dec 15.
8
Provision of individualized information to men and their partners to facilitate treatment decision making in prostate cancer.向男性及其伴侣提供个性化信息,以促进前列腺癌治疗决策的制定。
Oncol Nurs Forum. 2003 Jan-Feb;30(1):107-14. doi: 10.1188/03.ONF.107-114.
9
Evidence-based patient choice: a prostate cancer decision aid in plain language.循证患者选择:一份通俗易懂的前列腺癌决策辅助工具
BMC Med Inform Decis Mak. 2005 Jun 20;5:16. doi: 10.1186/1472-6947-5-16.
10
Regret in men treated for localized prostate cancer.接受局限性前列腺癌治疗的男性的遗憾。
J Urol. 2003 Jun;169(6):2279-83. doi: 10.1097/01.ju.0000065662.52170.6f.

引用本文的文献

1
Concordance between influential adverse treatment outcomes and localized prostate cancer treatment decisions.有影响力的不良治疗结局与局限性前列腺癌治疗决策之间的一致性。
BMC Med Inform Decis Mak. 2022 Aug 24;22(1):223. doi: 10.1186/s12911-022-01972-w.
2
Improving Shared Decision Making in Latino Men With Prostate Cancer: A Thematic Analysis.改善拉丁裔前列腺癌男性患者的共同决策:一项主题分析。
MDM Policy Pract. 2021 May 27;6(1):23814683211014180. doi: 10.1177/23814683211014180. eCollection 2021 Jan-Jun.
3
Implementation of prostate cancer treatment decision aid in Michigan: a qualitative study.
密歇根州前列腺癌治疗决策辅助工具的实施:一项定性研究。
Implement Sci Commun. 2021 Mar 6;2(1):27. doi: 10.1186/s43058-021-00125-w.
4
Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemic.根治性前列腺切除术的时机和延迟并不会导致不良的肿瘤学结果:COVID-19 大流行时期大型欧洲队列研究的结果。
World J Urol. 2021 Jun;39(6):1789-1796. doi: 10.1007/s00345-020-03402-w. Epub 2020 Aug 10.
5
Communicating the External Beam Radiation Experience (CEBRE): Perceived Benefits of a Graphic Narrative Patient Education Tool.交流体外放射治疗体验(CEBRE):图形叙事患者教育工具的感知益处。
Pract Radiat Oncol. 2020 Jul-Aug;10(4):e219-e226. doi: 10.1016/j.prro.2019.09.001. Epub 2019 Sep 11.
6
Factors underlying treatment decision-making for localized prostate cancer in the U.S. and Canada: A scoping review using principal component analysis.美国和加拿大局部前列腺癌治疗决策的潜在因素:一项使用主成分分析的范围综述。
Can Urol Assoc J. 2019 Jul;13(7):E220-E225. doi: 10.5489/cuaj.5538.
7
Understanding health decision making: An exploration of homophily.理解健康决策:同质性的探索。
Soc Sci Med. 2018 Oct;214:118-124. doi: 10.1016/j.socscimed.2018.08.026. Epub 2018 Aug 24.
8
Patient, physician, and caregiver perspectives on ovarian cancer treatment decision making: lessons from a qualitative pilot study.患者、医生及护理人员对卵巢癌治疗决策的看法:一项定性试点研究的经验教训
Pilot Feasibility Stud. 2018 Jul 4;4:91. doi: 10.1186/s40814-018-0283-7. eCollection 2018.
9
Do psychological harms result from being labelled with an unexpected diagnosis of abdominal aortic aneurysm or prostate cancer through screening? A systematic review.通过筛查意外诊断出腹主动脉瘤或前列腺癌并被贴上标签会导致心理伤害吗?一项系统综述。
BMJ Open. 2017 Dec 12;7(12):e017565. doi: 10.1136/bmjopen-2017-017565.
10
Influence of Men's Personality and Social Support on Treatment Decision-Making for Localized Prostate Cancer.男性人格特质与社会支持对局限性前列腺癌治疗决策的影响
Biomed Res Int. 2017;2017:1467056. doi: 10.1155/2017/1467056. Epub 2017 Jul 12.